{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Peng Y"],"funding":["Third Military Medical University"],"pagination":["5623601"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8546404"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["2021"],"pubmed_abstract":["<h4>Background and aims</h4>Hepatic encephalopathy (HE) is characterized by recurrence and poor quality of life. Acute-on-chronic liver failure (ACLF) mainly occurs in patients with chronic liver diseases and often presents with HE. Several predictive models have been proposed to predict the outcomes of these patients. Our study is aimed at identifying associated risk factors and the prognostic accuracies of predictive models in HE patients with or without ACLF.<h4>Methods</h4>Patients with liver cirrhosis were retrospectively enrolled. Risk factors were evaluated by multivariate regression analyses. The predictive capabilities of models were calculated using the receiver operating characteristic (ROC) curve analyses and compared by the DeLong tests. Outcomes were defined as in-hospital mortality, HE severity, and ACLF occurrence.<h4>Results</h4>In multivariate regression analyses, serum biomarkers neutrophil and total bilirubin (TBIL) were independently correlated with in-hospital death. Alanine aminotransferase (ALT) and blood urea nitrogen (BUN) were independent serum biomarkers associated with HE severity. Hemoglobin, TBIL, BUN, and international normalized ratio (INR) were significant indicators associated with ACLF incidence. For prediction of in-hospital mortality, Child-Pugh was superior to the others in the whole patients, while NLR showed the best capability in the ACLF group.<h4>Conclusion</h4>In cirrhotic patients present with HE, BUN is a risk factor associated with HE severity and ACLF incidence. Child-Pugh and NLR scores may be effective prognosticators in patients with HE."],"journal":["Gastroenterology research and practice"],"pubmed_title":["Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy."],"pmcid":["PMC8546404"],"funding_grant_id":["XZ-2019-505-001","81922012"],"pubmed_authors":["Peng Y","Liu Y","Wu Z","Wei Q","Zhang H","Chai J","Wu H"],"additional_accession":[]},"is_claimable":false,"name":"Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy.","description":"<h4>Background and aims</h4>Hepatic encephalopathy (HE) is characterized by recurrence and poor quality of life. Acute-on-chronic liver failure (ACLF) mainly occurs in patients with chronic liver diseases and often presents with HE. Several predictive models have been proposed to predict the outcomes of these patients. Our study is aimed at identifying associated risk factors and the prognostic accuracies of predictive models in HE patients with or without ACLF.<h4>Methods</h4>Patients with liver cirrhosis were retrospectively enrolled. Risk factors were evaluated by multivariate regression analyses. The predictive capabilities of models were calculated using the receiver operating characteristic (ROC) curve analyses and compared by the DeLong tests. Outcomes were defined as in-hospital mortality, HE severity, and ACLF occurrence.<h4>Results</h4>In multivariate regression analyses, serum biomarkers neutrophil and total bilirubin (TBIL) were independently correlated with in-hospital death. Alanine aminotransferase (ALT) and blood urea nitrogen (BUN) were independent serum biomarkers associated with HE severity. Hemoglobin, TBIL, BUN, and international normalized ratio (INR) were significant indicators associated with ACLF incidence. For prediction of in-hospital mortality, Child-Pugh was superior to the others in the whole patients, while NLR showed the best capability in the ACLF group.<h4>Conclusion</h4>In cirrhotic patients present with HE, BUN is a risk factor associated with HE severity and ACLF incidence. Child-Pugh and NLR scores may be effective prognosticators in patients with HE.","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021","modification":"2025-04-04T22:43:27.048Z","creation":"2025-04-04T22:43:27.048Z"},"accession":"S-EPMC8546404","cross_references":{"pubmed":["34712321"],"doi":["10.1155/2021/5623601"]}}